Discovery of VU0467319: an M 1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials.

MLA

Poslunsey, Michael S., et al. “Discovery of VU0467319: An M 1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials.” ACS Chemical Neuroscience, vol. 16, no. 1, Jan. 2025, pp. 95–107. EBSCOhost, https://doi.org/10.1021/acschemneuro.4c00769.

APA

Poslunsey, M. S., Wood, M. R., Han, C., Stauffer, S. R., Panarese, J. D., Melancon, B. J., Engers, J. L., Dickerson, J. W., Peng, W., Noetzel, M. J., Cho, H. P., Rodriguez, A. L., Hopkins, C. R., Morrison, R., Crouch, R. D., Bridges, T. M., Blobaum, A. L., Boutaud, O., Daniels, J. S., … Lindsley, C. W. (2025). Discovery of VU0467319: an M 1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials. ACS Chemical Neuroscience, 16(1), 95–107. https://doi.org/10.1021/acschemneuro.4c00769

Chicago

Poslunsey, Michael S, Michael R Wood, Changho Han, Shaun R Stauffer, Joseph D Panarese, Bruce J Melancon, Julie L Engers, et al. 2025. “Discovery of VU0467319: An M 1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials.” ACS Chemical Neuroscience 16 (1): 95–107. doi:10.1021/acschemneuro.4c00769.